RxSight, Inc.
RXST · Ophthalmic Goods
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Weinberg Eric: Form 4
Insider disclosure · Filed · Report period 15 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- RXST · 78349D107 - Common Stock, par value $0.001 per share
Company details and SEC sources
CIK 0001111485 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- RXST on Nasdaq
- SEC industry group
- Ophthalmic Goods (Industrial Applications and Services)
- Business address
- 100 Columbia Street, Suite 120, Aliso Viejo, CA, 92656
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- CALHOUN VISION INC (to 20 Mar 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields